. Author manuscript; available in PMC: 2016 Jan 18.

Published in final edited form as: Endocr Relat Cancer. 2012 Apr 10;19(2):157–166. doi: 10.1530/ERC-11-0308

Table 2.

The differentially expressed miRNAs between benign and malignant pheochromocytomas identified by microarray analysis

Probe name	Mean log₂ (malignant/benign)	Fold difference (malignant/benign)	Raw P value	Adjusted P value^a
hsa-miRPlus-E1246^b	0.686	1.609	0.0017	0.010
hsa-miRPlus-E1030^b	0.932	1.908	0.0039	0.021
hsa-miR-183	0.813	1.757	0.0047	0.025
hsa-miR-483-5p	0.965	1.952	0.0088	0.042
hsa-miR-513a-5p	0.400	1.320	0.0130	0.057
hsa-miRPlus-E1106^b	0.198	1.147	0.0150	0.066
mmu-miR-710	0.449	1.365	0.0160	0.067
hsa-miR-101	−0.873	0.546	0.0190	0.078

Adjusted for false discovery rate using the Benjamini–Hochberg method.

Exiqon proprietary miRNA.